MRI-based risk stratification for predicting overall survival in pancreatic ductal adenocarcinoma
The M-PRiSM model can effectively predict pancreatic ductal adenocarcinoma survival. The M-PRiSM model showed strong generalizability in external validations. The M-PRiSM model stratifies patients for guiding adjuvant therapy for improved outcomes.
Authors
- Kai Liu (ORCID: https://orcid.org/0000-0001-9413-6782)
- Meng-Su Zeng (ORCID: https://orcid.org/0000-0003-3461-7423)
- Tianyu Lu (ORCID: https://orcid.org/0000-0002-7958-1594)
- Qiying Tang
- Yaolin Xu (ORCID: https://orcid.org/0000-0002-0971-518X)
- Minping Hong
- Haitao Sun
- Yiheng Zhou (ORCID: https://orcid.org/0000-0001-9207-3909)
- Jianbo Li (ORCID: https://orcid.org/0000-0001-7916-0944)
- Peng Wang
- Lei Li (ORCID: https://orcid.org/0000-0001-6401-1460)
- Junhee Han (ORCID: https://orcid.org/0000-0001-5736-8752)
- Jianjun Zhou
- Zongyu Xie (ORCID: https://orcid.org/0000-0003-1359-5157)
Institutions
- Jiangnan University (CN)
- Zhejiang Chinese Medical University (CN)
- Sun Yat-sen University (CN)
- Fudan University (CN)
- Jiaxing University (CN)
- Wuxi Fourth People's Hospital (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- First Hospital of Jiaxing (CN)
- First Affiliated Hospital of Bengbu Medical College (CN)
- Jingning County People's Hospital (CN)
Publication Details
- Journal
- Insights into Imaging
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1186/s13244-025-02088-1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Municipal Health Commission
- Natural Science Foundation of Zhejiang Province